Literature DB >> 17170397

Drug eluting stents are safe for licensed indications, FDA panel says.

Susan Mayor.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17170397      PMCID: PMC1702430          DOI: 10.1136/bmj.39063.481285.DB

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation.

Authors:  E G Marcos; A C Da Fonseca; S H Hofma
Journal:  Neth Heart J       Date:  2011-10       Impact factor: 2.380

2.  Risks and complications of transurethral resection of bladder tumor among patients taking antiplatelet agents for cardiovascular disease.

Authors:  Stefano Picozzi; Carlo Marenghi; Cristian Ricci; Giorgio Bozzini; Stefano Casellato; Luca Carmignani
Journal:  Surg Endosc       Date:  2013-09-04       Impact factor: 4.584

3.  The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use.

Authors:  Rainer Hoffmann; Helene Klinker; Umar Adamu; Malte Kelm; Rüdiger Blindt
Journal:  Clin Res Cardiol       Date:  2009-08-11       Impact factor: 5.460

4.  Endoscopic resection of bladder cancer in patients receiving double platelet antiaggregant therapy.

Authors:  Luca Carmignani; Stefano Picozzi; Robert Stubinski; Stefano Casellato; Giorgio Bozzini; Luca Lunelli; Domenico Arena
Journal:  Surg Endosc       Date:  2011-02-08       Impact factor: 4.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.